Dermata Therapeutics Faces Delisting Concerns
Ticker: DRMAW · Form: 8-K · Filed: May 16, 2025 · CIK: 1853816
| Field | Detail |
|---|---|
| Company | Dermata Therapeutics, Inc. (DRMAW) |
| Form Type | 8-K |
| Filed Date | May 16, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
Related Tickers: DRMA
TL;DR
DRMA is on the verge of being delisted, major red flag!
AI Summary
Dermata Therapeutics, Inc. filed an 8-K on May 16, 2025, reporting a notice of delisting or failure to meet continued listing standards as of May 14, 2025. The company is incorporated in Delaware and its principal executive offices are located in San Diego, California.
Why It Matters
This filing indicates potential issues with Dermata Therapeutics' ability to remain listed on its stock exchange, which could significantly impact its stock price and investor confidence.
Risk Assessment
Risk Level: high — The company has received a notice of delisting or failure to meet continued listing standards, which poses a significant threat to its operational viability and stock market presence.
Key Players & Entities
- Dermata Therapeutics, Inc. (company) — Registrant
- May 14, 2025 (date) — Earliest event reported
- May 16, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- San Diego, CA (location) — Principal executive offices
FAQ
What specific listing standard did Dermata Therapeutics fail to meet?
The filing does not specify the exact listing standard that Dermata Therapeutics failed to meet, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
When was the notice of delisting or failure to meet listing standards issued?
The notice was issued as of May 14, 2025, and reported in the 8-K filed on May 16, 2025.
What is the company's principal executive office address?
The principal executive offices are located at 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.
What is Dermata Therapeutics' state of incorporation?
Dermata Therapeutics, Inc. is incorporated in Delaware.
What is the SEC file number for Dermata Therapeutics?
The SEC file number for Dermata Therapeutics is 001-40739.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 16, 2025 regarding Dermata Therapeutics, Inc. (DRMAW).